- Original article
- Open Access
Assessment of severity of bronchial asthma by studying new markers: transforming growth factor-β1 and chitinase-3-like-1
The Egyptian Journal of Internal Medicine volume 28, pages 155–161 (2016)
The aim of this work was to look for non-invasive biomarkers that may enable us to assess asthma severity, as a surrogate for the invasive bronchial mucosa biopsy, by studying TGF-β1 and YKL-40.
TGF-β1 is used as biomarkers in the pathogenesis, prediction and follow up of asthma severity. YKL-40 has a role in airway inflammation; this relation suggests that YKL-40 and TGF-β1 can be used as biomarkers in the pathogenesis, prediction and follow-up of asthma severity.
Defective extracellular matrix (ECM) turnover characterizes airway remodeling. Transforming Growth Factor Beta-1 (TGF-β1) stimulate airway remodeling through activation of gene transcription via binding to specific subfamilies of cell transmembrane receptors.
The work was done on a 60 subject aged between 20–40 years with equal sex. Classified into three groups; 20 patients with mild asthma, 20 patients with severe asthma and 20 normal subjects were taken as controls. For all subjects chest X-ray, pulmonary functions tests, allergy skin prick test, eosinophilic count, total IgE, YKL-40 and TGF-β1 in serum were performed.
The results showed that serum TGF-β1 and serum YKL-40 between the three groups were highly significantly different (P<0.01) between the three groups in asthmatic patients compared with control group.
These variations were correlated positively with the severity of the disease indicating that their increased serum levels may be a biological characteristic of the disease exacerbation with a sentinel role in asthma.
Yang YC, Zhang N, van Crombruggen K, Hu GH, Hong SL, Bachert C. Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012; 67:1193–1202.
Mirzamani MS, Nourani MR, Fooladi AAI, Zare S, Ebrahimi M,Yazdani S, et al. Increased expression of TGF-B1 and receptors in primary human airway fibroblast from chemical inhalation patients. Iran J Allergy Asthma Immunol 2013; 12:144–152.
Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc 2009; 59:698–702.
Saba M, Sharif MR, Akbri H, Nikoueinejad H, Jolfaii MR. YKL-40 in asthma and its correlation with different clinical parameters. Iran J Allergy Asthma Immunol 2014; 13:271–277.
Possa SS, Leick EA, Prado CM, Martins MA, Tibério IF. Eosinophilic inflammation in allergic asthma. Front Pharmacol 2013; 4:46.
Ito R, Gon Y, Nunomura S, Atsuta R, Harada N, Hattori T, et al. Development of assay for determining free IgE levels in serum from patients treated with omalizumab. Allergol Int 2014; 63(Suppl 1): 37–47.
Wang X, Xing GH. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome. Scand J Clin Lab Invest 2014; 74:74–78.
Benson DM, Caligiuri MA. Cancer immunology at the crossroads: killer immunoglobulin-like receptors and tumor immunity. Cancer Immunol Res 2014, 2:99–104.
Hassan NAE, Mohamed-Hussein AAR, Mohammed EF, Mohamed OAE, Mohamed HO, et al. Serum transforming growth factor-β1 (TGF-β1) in asthmatics: association between disease control, severity and duration. Biochem Anal Biochem 2015; 4:200.
Manuyakorn W, Kamchaisatian W, Atamasirikul K, Sasisakulporn C, Direkwattanachai C, Benjaponpitak S. Serum TGF-β1 in atopic asthma. Asian Pac J Allergy Immunol 2008 26:185–189.
Joseph J, Benedict S, Badrinath P, Wassef S, Joseph M, Abdulkhalik S, Nicholls MG. Elevation of plasma transforming growth factor beta1 levels in stable non atopic asthma. Ann Allergy Asthma Immunol 2003; 91:472–476.
Ozyilmaz E, Canbakan S, Capan N, Erturk A, Gulhan M. Correlation of plasma transforming growth factor beta 1 with asthma control test. Allergy Asthma Proc 2009; 30:35–40.
El-Sayed ZA, El-Hakim IZ, El-Kerdani TA, Ghanem HM. Serum transforming growth factor-beta1 in asthmatic children. Egypt J Pediatr Allergy Immunol 2004; 2:46–51.
Chu HW, Trudeau JB, Balzar S, Wenzel SE. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000; 106:1115–1123.
Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. Transforming growth factor-beta1 in asthma; measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156:642–647.
Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al. A chitinaselike protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007; 357:2016–2027.
Kuepper M, Bratke K, Virchow JC. Chitinase-like protein and asthma. N Engl J Med 2008; 358:1073–1075.
Ober C, Chupp GL. The chitinase and chitinase like proteins: a review of genetic and functional studies in asthma and immunemediated diseases. Curr Opin Allergy Clin Immunol 2009; 9: 401–408.
Shuhui L, Mok YK, Fred WS. Role of mammalian chitinases in asthma. Int Arch Allergy Immunol 2009; 149:369–377.
Tang H, Fang Z, Sun Y, Li B, Shi Z, Chen J, et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010; 35:757–760.
Sohn MH, Lee JH, Kim KW, Kim SW, Lee SH, Kim KE, et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009; 179:449–456.
Duru S, Yüce G, Ulasli SS, Erdem M, Murat K, Fatma K, Sadik A. The relationship between serum YKL-40 levels and severity of asthma. Iran J Allergy Asthma Immunol 2013; 12:247–2453.
Rotsides DZ, Goldstein IF, Canfield SM, Perzanowski M, Mellins RB, Hoepner L, et al. Asthma, allergy, and IgE levels in NYC head start children. Respir Med 2010; 104:345–355.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms
About this article
Cite this article
Lotfy, A.M., Khalil, F., Zidan, H. et al. Assessment of severity of bronchial asthma by studying new markers: transforming growth factor-β1 and chitinase-3-like-1. Egypt J Intern Med 28, 155–161 (2016). https://doi.org/10.4103/1110-7782.203295
- asthma severity